Therapeutic potential of a TrkB agonistic antibody for Alzheimer's disease_Publication_News_4B Technologies (Beijing) Co., Limited

About

Science

Pipeline

Partnership

News

Career

Contact

Therapeutic potential of a TrkB agonistic antibody for Alzheimer's disease

Release date: May 23, 2020

Therapeutic potential of a TrkB agonistic antibody for Alzheimer’s disease_页面_01

Therapeutic potential of a TrkB agonistic antibody for Alzheimer’s disease_页面_02

Therapeutic potential of a TrkB agonistic antibody for Alzheimer’s disease_页面_03

Therapeutic potential of a TrkB agonistic antibody for Alzheimer’s disease_页面_04

Therapeutic potential of a TrkB agonistic antibody for Alzheimer’s disease_页面_05

Therapeutic potential of a TrkB agonistic antibody for Alzheimer’s disease_页面_06

Therapeutic potential of a TrkB agonistic antibody for Alzheimer’s disease_页面_07

Therapeutic potential of a TrkB agonistic antibody for Alzheimer’s disease_页面_08

Therapeutic potential of a TrkB agonistic antibody for Alzheimer’s disease_页面_09

Therapeutic potential of a TrkB agonistic antibody for Alzheimer’s disease_页面_10

Therapeutic potential of a TrkB agonistic antibody for Alzheimer’s disease_页面_11

Therapeutic potential of a TrkB agonistic antibody for Alzheimer’s disease_页面_12

Therapeutic potential of a TrkB agonistic antibody for Alzheimer’s disease_页面_13

Therapeutic potential of a TrkB agonistic antibody for Alzheimer’s disease_页面_14

Therapeutic potential of a TrkB agonistic antibody for Alzheimer’s disease_页面_15

Therapeutic potential of a TrkB agonistic antibody for Alzheimer’s disease_页面_16

Therapeutic potential of a TrkB agonistic antibody for Alzheimer’s disease_页面_17

Therapeutic potential of a TrkB agonistic antibody for Alzheimer’s disease_页面_18

Therapeutic potential of a TrkB agonistic antibody for Alzheimer’s disease_页面_19

Therapeutic potential of a TrkB agonistic antibody for Alzheimer’s disease_页面_20

Therapeutic potential of a TrkB agonistic antibody for Alzheimer’s disease_页面_21

Previous : An App knock-in rat model for Alzheimer's disease exhibiting Aβ and tau pathologies, neuronal death and cognitive impairments Next : TrkB agonistic antibodies superior to BDNF：Utility in treating motoneuron